PrEP for HIV prevention: what to know

PrEP has moved from a specialist topic into everyday conversation, but that doesn't mean everyone has a clear picture of what it actually is. If you've heard the term without a straightforward explanation, this article walks through what PrEP means, how it works, who current guidance focuses on, and what it does and doesn't protect against — so you can bring an informed question to a licensed clinician rather than piece it together from fragments online.

This is patient education, not medical advice. PrEP is not automatically right for everyone, and only an independent licensed medical professional can decide whether it is appropriate for you after an evaluation.

What PrEP is and how it works

PrEP stands for pre-exposure prophylaxis. In plain terms, it describes medication taken by a person who is HIV-negative, with the goal of reducing the risk of acquiring HIV if they are exposed through sex or, in some circumstances, injection drug use. The idea is preventive: the medication is already present in the body before any potential exposure occurs, rather than being started afterward.

The FDA has approved specific combination medications for this purpose, including emtricitabine/tenofovir disoproxil fumarate (Truvada®) and emtricitabine/tenofovir alafenamide (Descovy®). Both combine two antiretroviral medications that work by interfering with an early step HIV needs to establish infection in the body. Taken consistently as prescribed, this can substantially lower the chance that an exposure turns into an infection, though no medication removes risk entirely, and PrEP only works when it is actually taken on the schedule a clinician sets.

It's worth being precise about what PrEP is not. It is not a vaccine, it does not treat an existing HIV infection, and it is not a substitute for testing. It is one specific, evidence-based tool aimed at a specific job: lowering the risk of HIV acquisition in someone who does not currently have HIV.

Who PrEP is recommended for

Current public-health guidance generally focuses on people who are HIV-negative and have an ongoing possibility of exposure through sex or injection drug use, rather than the population as a whole. That might describe someone with a partner who is HIV-positive, someone with multiple partners and inconsistent condom use, or someone whose personal circumstances mean a meaningful, individually assessed likelihood of exposure over time.

Because everyone's circumstances are different, there isn't a single checklist that decides candidacy. Whether PrEP makes sense for you specifically is a clinical decision, made by a licensed clinician who reviews your sexual health history, testing history, and personal circumstances against current recommendations. Some people who ask about PrEP will be reasonable candidates; others may be better served by different prevention strategies, and a thoughtful clinician will say so honestly rather than prescribing by default.

Starting and monitoring PrEP with a clinician

Starting PrEP responsibly begins with testing, not a prescription pad. A negative HIV test is required before starting, because taking these medications while an HIV infection is already present, and undiagnosed, is not appropriate; it can allow the virus to develop resistance rather than prevent infection in the first place. That single step is one of the clearest safety reasons PrEP is a clinician-directed process rather than something to source informally.

Once PrEP is started, the relationship with a clinician continues. Regular retesting for HIV is part of standard care while on PrEP, along with periodic checks of kidney function, since these medications are processed by the kidneys, and screening for other STIs, since PrEP has no effect on them. A typical path looks like this:

1. An evaluation, covering sexual health history, current testing, other medications, and individual risk.
2. A confirmed negative HIV test, along with baseline kidney function and other relevant labs.
3. Clinician review, where an independent licensed professional weighs current guidance and decides whether PrEP is appropriate for you.
4. Ongoing follow-up, with scheduled retesting and monitoring for as long as you continue PrEP.

That follow-up isn't a formality; it's the mechanism that keeps PrEP both effective and safe over time. A responsible service treats PrEP as an ongoing relationship with monitoring built in, not a one-time transaction.

Safety, side effects, and monitoring

Most people tolerate PrEP medications well. When side effects occur, they are often mild and temporary — nausea, headache, decreased appetite, or stomach upset, particularly in the first weeks, which tends to ease as the body adjusts. As with any prescription medication, individual experiences vary, and any side effect worth mentioning is worth mentioning to your clinician rather than managing alone.

Because these medications are processed by the kidneys, clinicians monitor kidney function periodically while someone is on PrEP. There are also specific considerations for people who have chronic hepatitis B: stopping PrEP medications can, in some cases, trigger a serious flare of hepatitis B, which is why any change in a PrEP regimen should happen under clinical guidance rather than being self-directed. None of this is meant to be alarming; it's the reason ongoing clinician oversight is part of standard PrEP care rather than an optional extra.

What PrEP does not protect against

This is the part most worth getting right. PrEP is specific to HIV. It does not protect against other sexually transmitted infections, including bacterial STIs like chlamydia and gonorrhea or viral infections such as herpes. Someone relying on PrEP as complete protection against sexually transmitted infections in general would be misunderstanding what it does.

Because of that limit, regular STI testing remains part of the picture for anyone on PrEP, along with other prevention layers such as condoms and open conversations with partners. You can find related explainers, including how a separate antibiotic-based approach is discussed for certain bacterial STIs, in our Sexual Health section, and our piece on DoxyPEP for STI prevention covers how that distinct approach works and where it does and doesn't overlap with PrEP.

How PrEP fits into a broader prevention plan

PrEP is most useful when it's understood as one component of a larger prevention strategy rather than a standalone solution. Sexual health rarely comes down to a single measure, and treating any one tool as a complete answer tends to leave gaps. A well-rounded approach often includes several elements working together:

• Regular HIV and STI testing, so that any infection is identified and addressed promptly.
• PrEP, for people whose circumstances and clinician evaluation support it, taken consistently as prescribed.
• Barrier methods such as condoms, which reduce transmission risk for infections PrEP does not address.
• Open communication with partners about testing history and risk, which supports informed, shared decisions.
• Ongoing clinician follow-up, so that your prevention plan can adjust as your circumstances change.

Seen this way, PrEP doesn't replace the rest of that list — it adds a meaningful layer for the right person. If you're weighing whether PrEP fits your situation, our What is DoxyPEP? and When to consider DoxyPEP articles are useful companion reading on how a related, but distinct, prevention approach is evaluated by a clinician.

Common questions people bring to a clinician

People exploring PrEP tend to arrive with a similar handful of questions, and naming them here may help you frame your own conversation. A common one is timing: how long does it take to reach full protection after starting? That answer depends on the specific medication and the type of exposure being considered, which is exactly the kind of detail a prescriber addresses individually rather than something to estimate from a general article.

Another frequent question is about daily life with PrEP — how it interacts with other medications, what happens if a dose is missed occasionally, and how testing and monitoring fit into a normal schedule. These are practical, answerable questions, and a clinician can walk through them so that taking PrEP feels manageable rather than burdensome.

Finally, many people ask the bigger question directly: is PrEP really the right choice for me? That instinct is the right one. Rather than deciding from an article or a friend's experience, bringing that question to a licensed clinician who can weigh your history and circumstances against current guidance is the responsible path, and an honest clinician will give you a straight answer either way.

The bottom line

PrEP is a specific, FDA-approved approach to reducing HIV risk in people who are HIV-negative, built around consistent use and clinician-directed monitoring. Its role is real but bounded: it addresses HIV specifically, it requires a confirmed negative HIV test to start and regular retesting to continue, and it does nothing against other sexually transmitted infections. Whether it's the right fit for you is always an individual clinical decision.

If any of this feels relevant to your circumstances, the best next step isn't to self-diagnose from an article but to talk with a licensed clinician who can review your history and current guidance together. That conversation is where a decision about PrEP belongs.

Frequently asked questions